1The Epithelial Transport Laboratory, Veteran's Affairs Greater Los Angeles Healthcare System (VISN 22), Sepulveda 91343; UCLA School of Medicine, Los Angeles, California 90024; and 2Department of Anatomy and Cell Biology, Queen's University, Kingston, Ontario K7L 3N6, Canada
Submitted 5 May 2003 ; accepted in final form 21 April 2004
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
annexin II; zonula occludens-1; occludin; claudin-1; hemifusion
Structurally, the tight junction is characterized by a linear fusion (20) or a series of focal fusions (20, 80) of juxtaposed exoplasmic lipid leaflets from adjacent epithelial or endothelial cells. Approximating cell membranes into molecular contact requires the displacement of water between the apposing hydrophilic surfaces of the interacting lipid bilayers and is a thermodynamically unfavorable process. Overcoming this high-activation energy barrier that opposes membrane fusion requires specialized fusion proteins (39, 81). Although a large number of tight junction proteins have been identified (27), many with adhesive properties, none is known to converge exoplasmic leaflets required in tight junction assembly. Thus the molecular basis for the original morphological observation of close approximation of or fusion between the exoplasmic lipid leaflets remains unknown. Annexin A2 (A2),1 in particular its heterotetramer (A2t), anchors the cytoplasmic leaflets of secretory vesicles to each other or to the plasma membrane (18, 55, 72). A2t added to the suspension of chromaffin granules (18, 51) or liposomes (51) forms junctions between these lipid bilayer structures through molecular bridging of their external lipid leaflets. Here, we provide morphological and functional evidence for a role of A2t in epithelial tight junction assembly.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Madin-Darby canine kidney (MDCK) II cell lines (a gift from Dr. R. Bacallao, Indiana University School of Medicine, Indianapolis, IN) were routinely cultured and propagated in T25 flasks with DMEM (Mediatech, Herndon, VA) plus 5% fetal calf serum, with penicillin and streptomycin, both at 100 U/ml. Cells were grown in 5% CO2 at 37°C and refed every third day. Serum weaning was accomplished by passaging serum-grown MDCK II cells through serum-containing medium, progressively diluted by serum-free medium, supplemented with human insulin and transferrin (UltraMDCK, Bio-Whittaker, Walkersville, MD). Cell viability was monitored, and cells were considered completely serum-weaned after three consecutive passages in the UltraMDCK media alone. At 95% confluence, cells were transferred to propagate in new T25 flasks or to grow on optically transparent Transwell membrane inserts (Corning Costar, Cambridge, MA) or glass coverslips (seeding at 0.5 x 106 cells/ml). Cells grown on transparent inserts were monitored daily for cell morphology, percent confluence, and transepithelial resistance (TER) and were used for confocal and electron microscopic studies. Cells grown on glass coverslips were used for immunofluorescence microscopic studies.
Cell Lysate Preparation
Cell lysates were prepared according to the protocol of Kendrick Laboratories (Madison, WI). Confluent MDCK II monolayers, grown in T75 flasks, were rinsed three times with cold PBS. One milliliter of Osmotic Lysis Buffer (10 mM Tris, pH 7.4, and 0.3% SDS), preheated in boiling water, was added directly to each flask to give a protein concentration of 24 µg/µl. After cooling on ice, 10 µl of x10 Nuclease Stock per 100 µl Osmotic Lysis Buffer were added and the cells were scraped from the flask using a rubber policeman, mixed with the solution, and incubated on ice for 30 min. An equal volume of SDS Boiling Buffer (5% SDS, 10% glycerol, and 60 mM Tris, pH 6.8) was then added and the mixture was heated in boiling water bath for 3 min. The samples were immediately quick-frozen in an ethanol/dry ice bath and stored at 70°C. The x10 Nuclease Stock solution (25) contained 50 mM MgCl2, 100 mM Tris, pH 7.0, 500 µg/ml RNase (Sigma R5125, Ribonuclease A from Bovine Pancreas Type IIIA), and 1,000 µg/ml DNase (Sigma D4527, Deoxyribonuclease I, Type II from bovine pancreas). The final concentration for these enzymes should be 50 µg/ml RNase and 100 µg/ml DNase in 5 mM MgCl2 and 10 mM Tris·HCl, pH 7.0.
2-D SDS-Polyacrylamide Gel Electrophoresis
2-D electrophoresis was performed according to the method of O'Farrell (64) by Kendrick Laboratories. Isoelectric focusing was carried out in glass tubes of 2.0-mm inner diameter, using 2.0% Resolytes, pH 48 ampholines (BDH from Hoefer Scientific Instruments, San Francisco, CA) for 9,600 V/h. One microgram of an isoelectric focusing internal standard, tropomyosin protein, was added to the samples. Tropomyosin shows two polypeptide spots of similar pI; the lower spot of molecular mass 33,000 and pI 5.2 is marked with an arrow on the Coomassie blue-stained 2-D gels (S; Fig. 1). After equilibration for 10 min in buffer O (10% glycerol, 50 mM dithiothreitol, 2.3% SDS, and 0.0625 M Tris, pH 6.8), the tube gels were sealed to the top of stacking gels that were on top of 10% acrylamide slab gels (0.75-mm thick) and SDS slab gel electrophoresis was carried out for 4 h at 12.5 mA/gel. The following proteins (Sigma, St. Louis, MO) were added as molecular mass standards to a well in the agarose that sealed the tube gel to the slab gel: myosin (220,000), phosphorylase A (94,000), catalase (60,000), actin (43,000), carbonic anhydrase (29,000), and lysozyme (14,000). These standards appear as horizontal lines on the Coomassie Brilliant Blue R-250-stained 10% acrylamide gels (Fig. 1). The Coomassie blue-stained gels were dried between sheets of cellophane with an acid edge to the left.
|
2-D gels were scanned with a Digital Instruments LGS 50 laser densitometer using an optical density range of 00.7 OD units. The images were further analyzed using Phoenix 2D Full software version 3.51, and the relative abundance of each polypeptide is expressed as a percentage of all the polypeptide spots scanned.
Identification of Polypeptides from 2-D Gels
This was performed at the Protein Chemistry Core Facility of Howard Hughes Medical Institute/Columbia University (New York, NY) based on published methods (22, 47). Gels containing the selected polypeptide spots (A and B in Fig. 1) were stained with 0.05% Coomassie Brilliant Blue G/0.5% acetic acid/20% methanol and destained with 30% methanol. The stained, excised polypeptide spots were soaked in water overnight and then transferred to a microcentrifuge tube and soaked in 500 µl of 0.1 M Tris, pH 9/50% acetonitrile for 30 min. The supernatant was discarded, and the wash was repeated four times. The washed gel pieces were placed on a clean glass plate to air dry for 510 min. To each gel piece was applied 2 µl of Lys-C (containing 0.0750.2 µg enzyme depending on the concentration of protein in each piece). The enzyme solution was absorbed by the gel after several minutes. Two to five microliters of digestion buffer (0.1 M Tris, pH 9/0.01% Tween 20) were applied to each piece of gel and allowed to soak in. The gel pieces were then submerged in 50 µl of digestion buffer and incubated for 20 h at 30°C. When digestion was complete, the supernatant was transferred to a Hewlett-Packard HPLC injection vial. The gel pieces were washed three times with 100 µl of 60% acetonitrile/0.1% TFA, soaking 30 min each time, and the supernatants were transferred to the injection vial. The combined washes in the injection vial were dried in a Speed-Vac concentrator and redissolved in 200 µl of 0.1% TFA for injection onto a HPLC column (Vydac C18, 0.21 x 15 cm). Analysis was carried out using a HP 1090 instrument under the following conditions: absorbance 210 nm, flow rate 0.2 ml/min, buffer A 0.075% TFA, buffer B 0.65% TFA in 80% acetonitrile, gradient 2% buffer B (010 min) and 275% buffer B (10120 min). Selected peaks were sequenced using an Applied Biosystems 477A sequencer (Applied Biosystems, Foster City, CA).
Immunofluorescence and Confocal Microscopy
Sample preparation is based on published protocols (5, 78) with modifications. In general, serum-weaned MDCK II cells grown into monolayers on optically transparent Transwell membrane inserts or glass coverslips were washed in PBS and fixed with 2% paraformaldehyde in PBS for 20 min at room temperature. After 30 min of blocking with PBS containing 3% nonfat milk (blocking buffer), primary antibodies were applied for 2 h at room temperature. The monolayers were then washed and incubated with secondary antibodies, either Cy3-conjugated anti-mouse or -rabbit IgG or FITC-conjugated anti-mouse or -rabbit IgG (Sigma BioSciences, St. Louis, MO) for 2 h at room temperature in the dark. The cells were then washed and mounted using SlowFade Antifade Kit (Molecular Probes, Eugene, OR). Blocking buffer was used for all washing and dilution of primary and secondary antibodies. For confocal microscopic localization of A2t subunits (Fig. 2), 90100% confluent monolayers on membrane inserts were washed in PBS before fixation with 2% paraformaldehyde in PBS for 20 min. The membranes were washed again with PBS, two times, and treated with 50 mM NH4Cl in PBS for 10 min at room temperature. After being washed in saponin buffer (0.075% saponin in PBS + 0.3% milk) for 10 min, the membranes were washed in PBS and treated with Triton X-100 (0.2% Triton X-100 in PBS) for 5 min at room temperature. The membrane inserts were then blocked with PBS and milk and stained with mouse monoclonal anti-A2 or mouse monoclonal anti-A2 light chain, p11 (BD Transduction Laboratories, Lexington, KY), both at a final concentration of 0.0167 mg/ml. The monolayers were then washed and incubated with secondary antibodies Cy3-conjugated anti-mouse IgG at 1:125 dilution. The images were analyzed using a Leica TCS Inverted Confocal Microscope at the Carol Moss Spivak Imaging Facility, University of California, Los Angeles. For colocalization of A2 and p11 subunits (Fig. 3), monolayers on glass coverslips were preextracted with extraction buffer (0.2% Triton X-100, 100 mM KCl, 3 mM MgCl2, 200 mM sucrose, 10 mM HEPES, pH 7.1), before fixing with 2% paraformaldehyde in PBS. The monolayers were then permeabilized with 0.1% Triton X-100 and washed according to the protocol above and stained with rabbit polyclonal anti-p11 (Biodesign International, Saco, ME) at 0.04 mg/ml concentration and mouse monoclonal anti-A2 at 0.008 mg/ml. Secondary antibodies FITC-conjugated anti-rabbit IgG and Cy3-conjugated anti-mouse IgG were applied at 1:30 and 1:250 dilutions, respectively. For the colocalization studies (Fig. 4) involving A2 subunit with tight junction proteins zonula occludens-1 (ZO-1), occludin, and claudin-1, glass coverslips containing 70100% confluent monolayers were stained with mouse monoclonal anti-A2 at a final concentration of 0.008 mg/ml and rabbit polyclonal anti-occludin, anti-ZO-1, or anti-claudin-1 (Zymed Laboratories, San Francisco, CA) at final concentrations of 0.005, 0.021, and 0.02 mg/ml, respectively. Secondary antibodies Cy3-conjugated anti-mouse IgG and FITC-conjugated anti-rabbit IgG were applied at 1:250 and 1:30 dilutions, respectively. Images of cell islands with well-established cell-cell contacts were obtained using an Olympus IX70 Microscope equipped with an RFC Reflected Light Fluorescence Attachment and visualized with the Olympus MagnaFire SP Digital Imaging System. Images were processed using Photoshop 6.0 (Adobe) software.
|
|
|
Electron Microscopy
Postembedding immunocytochemistry. Monolayers on Transwell membrane were first fixed with 1% paraformaldehyde in 0.1 M cacodylate buffer at room temperature and then placed on ice for 12 h. After being washed with cacodylate buffer, the preparations were partially dehydrated to 90% ethanol, infiltrated with LR White (London Resin White), and embedded in gelatin capsules at 50°C. Sections were cut with a DDK Diamond Knife on a Sorvall MT2-B Ultramicrotome and picked up on nickel grids. After citrate antigen retrieval, grids were stained as follows: blocked with 2.5% normal goat serum, 5% nonfat milk, and 0.1% cold fish gelatin in PBS, incubated with mouse monoclonal anti-A2, and rabbit polyclonal anti-occludin or anti-ZO-1, (all diluted 1:15 with PBS). Grids were then washed with PBS and incubated with goat anti-mouse IgG conjugated with 20 nm gold and goat anti-rabbit IgG conjugated with 10 nm gold (B B International) diluted 1:70 in PBS with cold fish gelatin. Grids were stained with uranyl acetate and lead citrate and viewed on a Philips 201c Electron Microscope.
Peptide Synthesis and Purification
Peptide A comprising the NH2-terminal 14 residues of A2 (AcSTVHEILCKLSLEG), including the N-acetyl group (Ac) of the terminal serine and Peptide S in which the sequence of the 14 residues was reversed, was synthesized on Wang resin via Fmoc chemistry. T-Butyl group was used for COOH (Glu/Asp) and NH2 group (Ser/Thr) protection; Trityl group for Cys and Gln side chain and Boc for Trp; Pbf for Arg. All materials were obtained from American Peptide (Sunnyvale, CA). The peptide chain was assembled on resin by repetitive removal of the Fmoc protecting group and coupling of protected amino acid. HBTU was used as a coupling reagent, and N-methylmorphiline was used as a base. After removal of the last Fmoc protecting group, resin was treated with TFA cocktail for cleavage and removal of the side chain protecting groups. Crude peptide was precipitated from cold ether and collected by filtration. Purification of crude peptide was achieved via RP-HPLC using 100 x 300-mm column. Packing media were obtained from Waters group. Analytic HPLC column (C18, 4.6 x 250 nm) was obtained from Vydac Separation Groups. Purified peptide was isolated by lyophilization and verified by mass spectroscopic analysis.
Calcium Chelation Studies
Serum-weaned cells were grown into confluent monolayers on 6.5-mm-diameter, optically transparent membrane inserts in Costar Transwell cell culture chamber (Corning Costar) in UltraMDCK media (1.4 mM Ca2+ concentration). Tight junction disassembly was achieved by transferring the inserts into Ca2+-free medium consisting of Minimum Essential Medium for Suspension (SMEM, Sigma BioSciences) plus 2 mM EGTA. Tight junction reassembly was induced by transferring the inserts back into UltraMDCK media. TER was monitored using a Millicell-ERS Electrical Resistance System (Millipore, Marlborough, MA). For details, see text and legends (see Fig. 7).
|
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We then proceeded to address the questions whether A2t is a structural component of the tight junction and whether it has a direct functional role in its assembly. Because serum can modify tight junction structure and function (11, 16, 58, 60), all subsequent studies were conducted using serum-weaned cells. Because there is no antibody directed against the A2t molecule, its cellular distribution is conventionally demonstrated by the use of antibodies against its subunits, A2 or p11. To validate the use of the A2 subunit as a marker for A2t, we first confirmed the identical localization of A2 and p11 at cell-cell contacts. This is demonstrated in both preconfluent (Fig. 3, top) and confluent (Fig. 3, bottom) monolayers. Note that the nuclear staining in the preconfluent monolayer is lost upon attainment of full confluence. Confluent monolayers also give the appearance of cell crowding (Fig. 3, bottom) with focal areas of multilayered growth (data not shown). Because certain junction assembly events are not observed in postconfluent monolayers with cell crowding (35, 82), subsequent images were obtained in cell islands with established cell-cell contacts in immediately preconfluent monolayers (70100% confluence).
Because the A2 subunit is distributed along the length of the lateral plasma membrane, including the tight junction area (Fig. 2, bottom), and because ZO-1 (15, 24, 68), occludin (15, 24, 68), or claudin-1 (23, 68) are established markers of the tight junction, colocalization of these proteins in x-z sections is predictable and will not be expected to yield additional information, especially at light microscopic resolutions. On the other hand, strong staining of A2 in the x-z sections, at the focal plane of known tight junction proteins, will provide additional support for the notion that A2 (although present along the whole length of the lateral membrane) is also present in quantity in the plane of the tight junction, in close proximity to bona fide tight junction markers. Figure 4 demonstrates the colocalization of A2 subunit with ZO-1 (A-C), occludin (D-F), or claudin-1 (G-I) in x-y sections at the focal plane of the tight junction. Note also the nuclear staining in all images, most apparent for A2 and ZO-1. The staining of ZO-1, a cytoplasmic protein, and claudin-1 using an antibody to a cytoplasmic epitope was accomplished in paraformaldehyde-fixed monolayers without postfixation permeabilization. Paraformaldehyde is known to alter membrane permeability, allowing antibodies and fluorochromes to reach cytoplasmic (34) and nuclear (54) targets. Although nuclear localization of A2 (19) and ZO-1 (28, 67) has been observed in preconfluent epithelial cells in the proliferative phase, we are not aware of any report on the nuclear presence of occludin and claudin-1. The basis for this observation is not addressed in this paper.
The predicted distribution of the tight junction proteins and their colocalization with A2t in longitudinal (x-z) sections of MDCK II monolayers is confirmed by immunoelectronmicroscopy. Figure 5 depicts ZO-1 (a) and occludin (b), both labeled with 10-nm gold particles, located in the most apical portion of the lateral plasma membrane, demarcating the tight junction. The A2 subunit of A2t (20-nm gold particles; c) is not only present in the tight junction region but also extends basally along the length of the lateral membrane and apically into the luminal membrane. Although most of the A2 subunit is present along or in close proximity to the cytoplasmic face of the plasma membrane, confirming the well-described submembranous distribution of A2t (26, 48, 83), many gold labels are also present in the intercellular space and over the external face of the plasma membrane (open arrowheads; c-e) consistent with prior observation of the presence of extracellular A2t (26, 44, 57, 83). Double labeling of A2, 20-nm gold particles (open arrowheads), with ZO-1 (d) or occludin (e), both 10-nm gold particles (filled arrowheads), confirms the close spatial association between A2t and the tight junction proteins. The colocalization of the A2 subunit with tight junction proteins, both at light microscopic (Fig. 4) and ultrastructural (Fig. 5) resolutions, leads to the question whether this molecule has a functional role in tight junction assembly.
|
|
To exclude the possibility of a nonspecific "peptide effect," the study was repeated with an additional treatment group using an acetylated scrambled peptide (Peptide S) in which the sequence of the 14 amino acids was reversed. Monolayers treated with Peptide S (1 mM) behaved exactly as the control monolayers (Fig. 7B). Again, except for a small rise of 5
/cm2, TER in the Peptide A-treated monolayers failed to recover after Ca2+ restoration. Intermittent replenishment with Peptide A (arrowheads), at 1 mM concentration, was needed to prevent TER recovery. No peptide replenishment was necessary in the first study (Fig. 7A). In four additional studies, the need for Peptide A replenishment to prevent tight junction reassembly varied between these two extremes. This variability in the requirement for fresh Peptide A suggests that some monolayers may have greater peptide-lytic activities, or greater A2t synthetic activities, or a combination of both. What is clear from all the six experiments is that the disruption of A2-p11 binding using Peptide A aborts tight junction reassembly following recovery from Ca2+ chelation.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Membrane fusion is an energetically unfavorable process and is accomplished in nature by special fusion molecules such as the SNARE proteins (69). Fusion between two separate phospholipid bilayer-enclosed aqueous compartments is accomplished first by the approximation and merger of the external leaflets of the two apposing phospholipid bilayers. This state of hemifusion is followed by the merger of the two internal lipid leaflets, thereby completing the fusion process and establishing a direct continuity between the two previously separate lipid bilayer-enclosed aqueous compartments (50). The tight junction, however, appears to represent a form of stable hemifusion that does not progress to complete fusion. This hemifusion may be mediated by proteins different from those of the SNARE family. Possible candidates include A2 and A2t, which are known to cross-link phospholipid membranes in a hemifusion state without progressing to full fusion (18, 51).
A2 is a member of the ubiquitous annexin protein family (26, 48, 83). All proteins of this evolutionary conserved multigene family exhibit the property of binding acidic, negatively charged phospholipids in a Ca2+-dependent fashion. A2 is expressed in three molecular configurations: a monomer (A2), a heterodimer (A2d), and a heterotetramer (A2t). A2 is distributed predominantly in the cytoplasm. The heterodimer, formerly known as the primer recognition protein, consists of one subunit each of A2 and 3-phosphoglycerate kinase, is associated with the nucleus, and regulates DNA polymerase -activities. The heterotetramer, made up of two copies each of A2 and p11, is localized to the plasma membrane (83). A2 and A2t not only bind to but also aggregate or cross-link phospholipid membranes without inducing complete fusion (18, 51). However, although A2 aggregates chromaffin granules with a Kd [Ca2+] {[Ca2+] for half-maximal granule aggregation} of
1 mM, A2t initiates granule aggregation at a threshold [Ca2+] of 0.7 µM and exhibits a Kd [Ca2+] of 1.8 µM (18). The low micromolar [Ca2+] requirement for membrane aggregation renders A2t an ideal candidate for mediating membrane-membrane interactions in the intracellular environment.
Early studies confirmed A2t is an important intracellular membrane-bridging protein (18, 55, 72). Ultrastructural analysis in intact tissues reveals A2t anchors secretory vesicles/granules to each other or to the cytoplasmic face of the plasma membrane setting the stage, respectively, for vesicular fusion and vesicle-plasma membrane fusion and secretion (61, 71, 72). These studies were paralleled by in vitro studies in which the addition of exogenous A2t to suspension of isolated chromaffin granules (18, 51) or liposomes (51) induced aggregation and junction formation between these lipid bilayer-encased structures without inducing complete fusion. A2t-induced junction formation between liposomes (devoid of other proteins) provides conclusive evidence for its role in junction assembly.
A proposed molecular mechanism for bridging the external leaflets from adjacent lipid bilayers is depicted in Fig. 6. Similar to all annexins, the A2 molecule consists of a highly conserved COOH-terminal protein core domain (C-domain) and a NH2-terminal domain (N-domain) that is variable in length and composition in different annexins. The protein core is composed of a stretch of 70 amino acids, which is repeated four times (in the case of annexin VI, eight times). Each repeat folds into five -helices, which are, in turn, wound into a right-hand superhelix. The four repeats are arranged in a planar cyclic array, shaping the molecule into a slightly curved disk with a convex and a concave side (53). Ca2+-binding sites are located on the convex face, whereas the NH2- and COOH-terminus are located on the concave surface. Each A2 subunit of an A2t molecule binds to the outer phospholipid leaflet of one lipid bilayer along its convex face and to the p11 dimer along its concave face. The A2-outer phospholipid leaflet binding is mediated through a calcium-bridging mechanism in which a Ca2+ molecule links the Ca2+-binding site of the A2 subunit to the negatively charged phospholipid leaflet (48, 76).
Our study suggests that A2t may assemble tight junctions in a similar fashion, i.e., by molecular linkage of the exoplasmic leaflets from adjacent lipid bilayers. This is supported by both structural and functional evidence. Based on 2-D gel analysis and microsequencing, we demonstrated A2 as a major protein in MDCK II monolayers (Fig. 1). Confocal microscopic analysis revealed predominant localization of A2, as is p11, along the apical and lateral plasma membranes (Fig. 2); consistent with prior reports that 9095% of epithelial A2 is distributed along the plasma membrane as an A22-p112 heterotetramer (26, 37). After confirming the identical localization of A2 and p11 at cell-cell contacts (Fig. 3), we demonstrated the colocalization of A2t (using the A2 subunit as a marker) with tight junction proteins both at light microscopic (Fig. 4) and ultrastructural (Fig. 5) resolutions. Immunoelectronmicroscopy confirms the presence of ZO-1 (Fig. 5a) and occludin (Fig. 5b) in the tight junction domain and demonstrates the presence of many gold-labeled A2 subunits in the intercellular space and along the extracellular face of the lateral plasma membrane (Fig. 5c). Ultrastructural proximity of A2t with ZO-1 (Fig. 5d) and occludin (Fig. 5e) further supports a role of this molecule in tight junction assembly. However, the morphological data up to this point cannot conclusively exclude the possibility that A2 by itself as a monomer, rather than A2t, is responsible for the assembly of the tight junction. This possibility is consistent with reports that A2 also induces junction formation between liposomes (51) and that, similar to A2t, it is present on the extracellular face of the plasma membrane. However, the observation that targeted disruption of A2t using Peptide A, which specifically dissociates p11 from A2, aborts tight junction reassembly in Ca2+-chelation studies (Fig. 7) supports A2t, rather than A2, as the dominant player. In addition, the observation that the presence of Peptide A in the incubation medium aborts the anticipated TER recovery supports a critical role for intact, extracellular A2t in tight junction assembly.
Although the presence of A2 (13, 33, 56, 73, 79) and A2t (44, 46, 57, 86) on the extracellular face of the plasma membrane is well documented, an understanding of the export mechanism for these classical intracellular proteins has only begun to emerge. Although annexin proteins do not have the hydrophobic sequence required for the canonical secretory pathway (26, 83), externalization of A2 (21) and A2 and p11 (43) through nonclassical secretory pathways has been demonstrated. More recently, Zhao and associates (89) provided direct evidence for A2 secretion through the activation of the insulin receptor, the insulin-like growth factor receptor, and their signaling pathways.
The mechanism mediating the binding between the A2 subunit of A2t and the exoplasmic leaflet of the plasma membrane is also not well defined. The calcium-bridging mechanism (48, 76) discussed earlier is not directly applicable here because, unlike the external leaflets of the chromaffin granules and the liposomes or the cytoplasmic leaflet of the plasma membrane, all of which are enriched with negatively charged phosphatidylserine, the exoplasmic leaflet of the plasma membrane consists predominantly of phosphatidylcholine and sphingomyelin, which exhibit no net charge (75). However, recent studies indicate that in addition to the Ca2+-bridging mechanism, A2 and A2t also bind directly to cholesterol of the lipid membrane (3, 26, 88). Nusrat and associates (63) demonstrated that tight junctions are membrane microdomains that are cholesterol-sphyingolipid-enriched membrane structures (74). Moreover, in these cholesterol-rich membrane microdomains, Kunzelmann-Marche and associates (49), using human erythroleukemia cells, observed the externalization of phosphatidylserine from the cytoplasmic leaflet to the exoplasmic leaflet of the plasma membrane. This lipid asymmetry is dependent on microdomain integrity and is lost with its disruption. Thus in the tight junction microdomains, A2t may link the adjacent exoplasmic leaflets through cholesterol or Ca2+ bridges, or a combination of both. In addition, Kassam et al. (44) noted a high affinity of A2t for heparin and speculated that A2t may bind with cell surface heparan sulfate glycosaminoglycan.
Many studies demonstrated E-cadherin (formerly known as uvomorulin and a major structural and functional component of the adherens junction) is important in the formation and maintenance of the tight junction (8, 31, 85). Ando-Akatsuka et al. (2) observed colocalization of E-cadherin and ZO-1 to early cell-cell contacts. As the contact matures, ZO-1 recruits occludin to form the tight junction, whereas E-cadherin constitutes the more basal adherens junction. More detailed analyses of cadherin-induced cell-cell contacts demonstrate that cellular protrusions from one cell indent and embed into the plasma membrane of a second cell (1, 82). At the tip of each protrusion is a spot-like punctum formed by the clustering of transmembrane cadherin molecules and their accessory proteins. On tissue sections, the puncta at the tips of protrusions from each of the two junction-forming cells line up in a row and together form a two-row zipper-like structure. Stabilization and reorganization of this "adhesion zipper" eventually seal the opposing membranes (1, 82). However, one issue remains unresolved: although the adhesive action of the cadherins and their accessory proteins is well established, these proteins are not known to exhibit membrane-sealing or -fusion properties. We propose the heterotetramer of A2 is the missing sealing molecule in these studies. This is supported by the recent observation that A2 (as a subunit of its tetrameric moiety) accumulates at cadherin-driven cell-cell contacts (35) where, in earlier observations (1, 82), opposing membranes were seen to "zip" close.
The distribution of A2t along the length of the apical and lateral plasma membrane (Figs. 2 and 5), outside the tight junction, is consistent with prior reports and with its other known biological actions, which include Ca2+-dependent exocytosis, endocytosis, and cell-cell adhesion (26, 48, 83). On the cytoplasmic side of the plasma membrane, A2t has been observed as ultrastructural strands of 78 nm (7080 ) to as long as 80 nm (800
) that link secretary granules to each other or to the plasma membrane (61, 72). Our observation of the basal extension of extracellular A2t beyond the tight junction (Fig. 5c, open arrowheads) raises the possibility that A2t may also link lateral plasma membranes from apposing cells and thereby regulate the dimension and configuration of the intercellular space beyond and basal to the tight junction. In addition, the possibility that the tight junction can dynamically extend its depth basally is suggested by the study of Diamond and Tormey (17), who reported the absence of intercellular space between adjacent cells in gall bladder epithelia in which water transport was arrested. Kachar and Pinto da Silva (41) reported that tight junction assembly could be induced along the entire length of the lateral plasma membrane in rat prostatic epithelial cells. Because tight junction strand formation was rapid (within 5 min) and occurred in the presence of protein synthesis inhibitor and metabolic uncoupler, they proposed that the assemblage was carried out by "preexisting components...of the lateral plasma membrane." We postulate A2t as a possible candidate for their proposed "preexisting components."
In conclusion, we propose that A2t plays a role in tight junction assembly possibly through linking juxtaposed exoplasmic leaflets to form a lipid platform across the intercellular space (42, 65). Into this lipid platform other tight junction proteins such as the occludin, the claudins, and the JAM insert and regulate permeability across epithelial or endothelial sheets. On the cytoplasmic face of the plasma membrane, A2t has been shown to participate in membrane microdomain assembly, on the one hand (4, 36), and to link the plasma membrane to the cytoskeleton, on the other hand (77, 90). Recent studies indicate that the tight junction lipid microdomain assembles a large number of macromolecules responsible for the regulation of cell polarity and cell growth and differentiation (63, 87). Thus A2t appears to play a role in all the known functions of the tight junction, i.e., permeability, polarity, and signal transduction as well as growth regulation.
![]() |
GRANTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
FOOTNOTES |
---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 New annexin nomenclature endorsed by participants at the 50th Harden Conference on Annexins held at Wye College, UK, September 15, 1999 (26). Details are posted at the European annexin website (http://www24.brinkster.com/annexins/).
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|